Joint Filing Agreement
EXHIBIT 1
Pursuant to Rule 13d-1(k)(1) of the Securities Exchange Act of 1934, each of the parties to this Joint Filing Agreement (this “Agreement”) agrees that the statement on Schedule 13G with respect to the common stock issued by Genaissance Pharmaceuticals, Inc., to which this Agreement is attached as an Exhibit, is filed on behalf of each such party and that any amendments to the attached Schedule 13G will likewise be filed on behalf of each such party.
IN WITNESS WHEREOF, the undersigned have caused this Joint Filing Agreement to be executed on November 7, 2003.
|
RAM TRADING, LTD. |
|||||||
|
|
|||||||
|
By: |
Xxxxxxx
Capital Management, L.L.C., its |
||||||
|
|
|
||||||
|
|
|
||||||
|
|
By: |
/s/ A.R. Xxxxx Xxxxxxx |
|
||||
|
|
|
Name: |
A.R. Xxxxx Xxxxxxx |
||||
|
|
|
Title: |
Chief Executive Officer |
||||
|
|
|
||||||
|
|
|
||||||
|
XXXXXXX CAPITAL MANAGEMENT, L.L.C. |
|||||||
|
|
|
||||||
|
|
|
||||||
|
By: |
/s/ A.R. Xxxxx Xxxxxxx |
|
|||||
|
|
Name: |
A.R. Xxxxx Xxxxxxx |
|||||
|
|
Title: |
Chief Executive Officer |
|||||
|
|
|
|
|||||
|
|
|
|
|||||
|
RAM CAPITAL, L.L.C. |
|||||||
|
|
|
||||||
|
By: |
Xxxxxxx
Capital Management, L.L.C., its |
||||||
|
|
|
||||||
|
|
|
||||||
|
|
By: |
/s/ A.R. Xxxxx Xxxxxxx |
|
||||
|
|
|
Name: |
A.R. Xxxxx Xxxxxxx |
||||
|
|
|
Title: |
Chief Executive Officer |
||||
|
RAM CAPITAL INVESTMENTS, LTD. |
|||||||
|
|
|||||||
|
By: |
Xxxxxxx
Capital Management, L.L.C., its |
||||||
|
|
|
||||||
|
|
|
||||||
|
|
By: |
/s/ A.R. Xxxxx Xxxxxxx |
|
||||
|
|
|
Name: |
A.R. Xxxxx Xxxxxxx |
||||
|
|
|
Title: |
Chief Executive Officer |
||||
|
|
|
||||||
|
|
|
||||||
|
THR, INC. |
|||||||
|
|
|
||||||
|
|
|
||||||
|
By: |
/s/ A.R. Xxxxx Xxxxxxx |
|
|||||
|
|
Name: |
A.R. Xxxxx Xxxxxxx |
|||||
|
|
Title: |
Chief Executive Officer |
|||||
|
|
|||||||
|
|
|||||||
|
/s/ A.R. Xxxxx Xxxxxxx |
|
||||||
|
A.R. Xxxxx Xxxxxxx |
|||||||
2